04:53 PM EDT, 10/10/2024 (MT Newswires) -- Heron Therapeutics ( HRTX ) said Thursday it can continue supplying its ready-to-administer chemotherapy-induced and postoperative nausea and vomit prevention medications Cinvanti, Sustol, and Aponvie amid the expected shortage of intravenous fluids caused by Hurricane Helene.

The expected disruption in IV fluid supply is due to the temporary closure of a major manufacturing facility in Marion, North Carolina, which was impacted by Hurricane Helene, the company said.

Price: 1.8500, Change: +0.03, Percent Change: +1.65